News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,576 Results
Type
Article (13798)
Company Profile (101)
Press Release (251677)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88082)
Career Advice (465)
Deals (15346)
Drug Delivery (67)
Drug Development (36607)
Employer Resources (49)
FDA (6292)
Job Trends (6199)
News (150263)
Policy (14037)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (32)
Alliances (23224)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (37)
Approvals (6328)
Artificial intelligence (106)
Autoimmune disease (9)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (77)
Cancer (599)
Cardiovascular disease (70)
Career advice (407)
Career pathing (11)
CAR-T (22)
Cell therapy (86)
Cervical cancer (4)
Clinical research (30909)
Collaboration (332)
Compensation (149)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (121)
Cystic fibrosis (37)
Data (622)
Denatured (15)
Depression (9)
Diabetes (78)
Diagnostics (1318)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (60)
Drug pricing (64)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32129)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37465)
Executive appointments (377)
FDA (6703)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (209)
Gene editing (38)
Generative AI (9)
Gene therapy (100)
GLP-1 (346)
Government (1296)
Grass and pollen (2)
Guidances (15)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (792)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (46)
Interviews (59)
IPO (5875)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (179)
Leadership (3)
Legal (3433)
Liver cancer (19)
Lung cancer (80)
Lymphoma (53)
Machine learning (1)
Management (16)
Manufacturing (149)
MASH (32)
Medical device (1276)
Medtech (1278)
Mergers & acquisitions (9674)
Metabolic disorders (256)
Multiple sclerosis (20)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (6)
Neuroscience (573)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (699)
Now hiring (7)
Obesity (146)
Opinion (119)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (46)
Partnered (7)
Patents (112)
Patient recruitment (28)
Peanut (10)
People (28925)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8043)
Phase II (13074)
Phase III (11737)
Pipeline (434)
Policy (68)
Postmarket research (1402)
Preclinical (3214)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (166)
Real estate (2637)
Recruiting (17)
Regulatory (10107)
Reports (14)
Research institute (565)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (36)
Series A (36)
Series B (12)
Service/supplier (3)
Sickle cell disease (32)
Southern California (717)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1630)
State (2)
Stomach cancer (3)
Supply chain (31)
Tariffs (20)
The Weekly (30)
United States (7100)
Vaccines (150)
Venture capitalists (13)
Weight loss (99)
Women's health (8)
Worklife (3)
Date
Today (58)
Last 7 days (171)
Last 30 days (888)
Last 365 days (11875)
2025 (3381)
2024 (12507)
2023 (14247)
2022 (19564)
2021 (20081)
2020 (19034)
2019 (14889)
2018 (11713)
2017 (13892)
2016 (13134)
2015 (15476)
2014 (12419)
2013 (10593)
2012 (11395)
2011 (11924)
2010 (10890)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20108)
Australia (2611)
California (1695)
Canada (897)
China (235)
Colorado (65)
Connecticut (67)
Delaware (54)
Europe (39415)
Florida (320)
Georgia (37)
Idaho (9)
Illinois (192)
India (16)
Indiana (132)
Iowa (1)
Japan (90)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (251)
Massachusetts (1462)
Michigan (30)
Minnesota (92)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (755)
New Mexico (7)
New York (495)
North Carolina (386)
North Dakota (2)
Northern California (699)
Ohio (49)
Oklahoma (4)
Oregon (16)
Pennsylvania (433)
Puerto Rico (8)
Rhode Island (8)
South America (502)
South Carolina (2)
Southern California (717)
Tennessee (34)
Texas (224)
Utah (33)
Virginia (72)
Washington D.C. (31)
Washington State (116)
Wisconsin (15)
265,576 Results for "eton pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
April 2, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
March 18, 2025
·
13 min read
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
Press Releases
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
March 4, 2025
·
7 min read
Press Releases
Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®
March 5, 2025
·
6 min read
Press Releases
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
March 14, 2025
·
4 min read
Press Releases
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
February 7, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
March 5, 2025
·
3 min read
Press Releases
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
February 7, 2025
·
4 min read
Press Releases
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
·
8 min read
1 of 26,558
Next
